Effects of K openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs

The Journal of Pharmacy and Pharmacology
Lara TestaiVincenzo Calderone

Abstract

This work evaluated the potential usefulness of pharmacological activation of cardiac ATP-sensitive potassium channels (K(ATP)) in the prevention of drug-induced QT prolongation in anaesthetised guinea-pigs. Prolongation of cardiac repolarisation and QT interval is an adverse effect of many drugs blocking HERG potassium channels. This alteration can be dangerously arrhythmogenic and has been associated with the development of a particular form of ventricular tachyarrhythmia known as torsade de pointes. The well-known K(ATP) openers aprikalim, cromakalim and pinacidil were used. Moreover, three benzothiazine derivatives, which have been reported as potent activators of K(ATP) channels, were also used. Pharmacological activation of K(ATP) channels caused a reduction of the QT prolongation, induced by astemizole, cisapride, quinidine and thioridazine. In contrast, the QT prolongation induced by haloperidol, sotalol and terfenadine, which are known to block HERG channels but also K(ATP) channels, was not influenced by K(ATP) activation. Glibenclamide and tolbutamide (non-selective blockers of K(ATP) channels expressed both in sarcolemmal and in mitochondrial membranes) antagonised the effects of K(ATP) openers, whereas 5-hydroxydec...Continue Reading

References

Oct 1, 1982·Chemical & Pharmaceutical Bulletin·K UekamaS Nomura
Jan 1, 1997·Journal of Pharmaceutical Sciences·C A SquierP W Wertz
Apr 1, 1997·The Journal of Pharmacy and Pharmacology·M V BentleyJ H Collett
Aug 28, 1998·Biomaterials·S Venkatraman, R Gale
Sep 22, 1998·Pharmaceutical Development and Technology·A C WilliamsB W Barry
Jun 27, 2000·International Journal of Pharmaceutics·J Hadgraft, C Valenta
Aug 28, 2001·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·E LarruceaP Ygartua
Oct 2, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·M SznitowskaA Baczek
Aug 23, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Surapanini Sridevi, Prakash Vaman Rao Diwan
Nov 29, 2002·Drug Development and Industrial Pharmacy·Linda A FeltonDonald A Godwin
Jan 29, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Heike WagnerUlrich F Schaefer
Sep 5, 2003·International Journal of Pharmaceutics·M M R DiasJ Hadgraft
May 4, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·B EvrardD Cataldo
Sep 29, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·S Narasimha MurthySek Wen Hui
Apr 5, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Domenico LombardoAntonino Mazzaglia
Jun 9, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Yiping WangBozena Michniak
Jun 9, 2005·International Journal of Pharmaceutics·Francesca MaestrelliPaola Mura
Jun 25, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·L KangS Y Chan
Sep 3, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Donald A GodwinLinda A Felton
Oct 18, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·N ZerroukP Mura
Oct 29, 2005·International Journal of Pharmaceutics·Stéphane GibaudAlain Astier
Jan 31, 2006·Bioorganic & Medicinal Chemistry Letters·Cécile Binkowski-MachutEric Monflier
Feb 3, 2006·International Journal of Pharmaceutics·Perry Fung Chye LimSui Yung Chan
Apr 4, 2006·International Journal of Pharmaceutics·C A VenturaG Puglisi
Jun 27, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anna M WokovichLucinda F Buhse
May 24, 2008·The Journal of Pharmacy and Pharmacology·Abubakr S ElgorashiW John Pugh
Nov 6, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Gavin P AndrewsDavid S Jones
Sep 8, 2009·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Anahita Fathi AzarbayjaniSui Yung Chan

❮ Previous
Next ❯

Citations

Oct 17, 2018·Materials·André Rodrigues Sá CoutoThorsteinn Loftsson
Oct 13, 2017·Basic & Clinical Pharmacology & Toxicology·Chutimon Muankaew, Thorsteinn Loftsson
May 13, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Phennapha SaokhamThorsteinn Loftsson
Sep 8, 2019·CNS Drugs·Angela AbruzzoFederica Bigucci
Jan 21, 2016·BioMed Research International·Vera Lucia Borges IsaacHelena Margarida Ribeiro
Apr 26, 2016·Expert Opinion on Drug Delivery·Joana MartoHelena M Ribeiro
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Manisha PrajapatiThorsteinn Loftsson
Dec 19, 2014·ACS Applied Materials & Interfaces·Sasha HoshianSami Franssila
Nov 10, 2017·Langmuir : the ACS Journal of Surfaces and Colloids·José Carlos BozelliRichard M Epand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.